Frontiers in Pharmacology (Jul 2023)
Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report
Abstract
No abstracts available.Keywords
Frontiers in Pharmacology (Jul 2023)